These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 33284825)

  • 1. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
    Ozturk S; Turgutalp K; Arici M; Odabas AR; Altiparmak MR; Aydin Z; Cebeci E; Basturk T; Soypacaci Z; Sahin G; Elif Ozler T; Kara E; Dheir H; Eren N; Suleymanlar G; Islam M; Ogutmen MB; Sengul E; Ayar Y; Dolarslan ME; Bakirdogen S; Safak S; Gungor O; Sahin I; Mentese IB; Merhametsiz O; Oguz EG; Genek DG; Alpay N; Aktas N; Duranay M; Alagoz S; Colak H; Adibelli Z; Pembegul I; Hur E; Azak A; Taymez DG; Tatar E; Kazancioglu R; Oruc A; Yuksel E; Onan E; Turkmen K; Hasbal NB; Gurel A; Yelken B; Sahutoglu T; Gok M; Seyahi N; Sevinc M; Ozkurt S; Sipahi S; Bek SG; Bora F; Demirelli B; Oto OA; Altunoren O; Tuglular SZ; Demir ME; Ayli MD; Huddam B; Tanrisev M; Bozaci I; Gursu M; Bakar B; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Ates K
    Nephrol Dial Transplant; 2020 Dec; 35(12):2083-2095. PubMed ID: 33275763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
    PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.
    Noor FM; Islam MM
    J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019.
    Rosenthal JA; Awan SF; Fintzi J; Keswani A; Ein D
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):93-95. PubMed ID: 33059035
    [No Abstract]   [Full Text] [Related]  

  • 13. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.
    Alguwaihes AM; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alzahrani SH; Sabico S; Al-Daghri NM; Jammah AA
    Cardiovasc Diabetol; 2020 Dec; 19(1):205. PubMed ID: 33278893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
    Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
    Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.
    Parra-Bracamonte GM; Lopez-Villalobos N; Parra-Bracamonte FE
    Ann Epidemiol; 2020 Dec; 52():93-98.e2. PubMed ID: 32798701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between chronic kidney disease and COVID-19-related mortality in New York.
    Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
    World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
    Dessie ZG; Zewotir T
    BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    Harrison SL; Fazio-Eynullayeva E; Lane DA; Underhill P; Lip GYH
    PLoS Med; 2020 Sep; 17(9):e1003321. PubMed ID: 32911500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.